CompletedNot Applicable

Microneedling-Assisted Delivery of Cetirizine Versus Latanoprost in Alopecia Areata

Egypt80 participantsStarted 2022-10-01

Plain-language summary

This study planned to measure the effectiveness and safety of microneedling aided administration of cetirizine 1% versus latanoprost 0.01% in alopecia areata.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Newly diagnosed cases of alopecia areata. * Patients of any age. * Both male and female patients. * Recent-onset patchy alopecia areata of ≤6 months' duration. * Presence of no more than two alopecia patches. * Stationary course of the disease. * Willingness to participate in the study. * Provision of written informed consent or parental/guardian consent for minors. Exclusion Criteria: * Extensive alopecia areata, including alopecia totalis or alopecia universalis. * Previous treatment of the alopecia areata lesions. * Active scalp infection. * Presence of associated dermatological, systemic, or autoimmune comorbidities. * Known allergy or hypersensitivity to any of the planned therapeutic agents.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Severity of Alopecia Tool Score (SALT Score)

Timeframe: Baseline and 12 weeks

Trial details

NCT IDNCT07757867

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-01

View on ClinicalTrials.gov More Microneedling-Assisted Delivery trials

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.